These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 15014711)
21. [Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the "Boulenger" study]. Chauvet-Gélinier JC Encephale; 2010 Oct; 36(5):425-32. PubMed ID: 21035633 [TBL] [Abstract][Full Text] [Related]
22. The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats. Mørk A; Kreilgaard M; Sánchez C Neuropharmacology; 2003 Aug; 45(2):167-73. PubMed ID: 12842122 [TBL] [Abstract][Full Text] [Related]
23. Escitalopram in major depressive disorder: clinical benefits and cost effectiveness versus citalopram. Lançon C; Verpillat P; Annemans L; Despiegel N; François C Int J Psychiatry Clin Pract; 2007; 11(1):44-52. PubMed ID: 24941275 [TBL] [Abstract][Full Text] [Related]
24. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram]. Favré P Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728 [TBL] [Abstract][Full Text] [Related]
25. Antidepressive therapy with escitalopram improves mood, cognitive symptoms, and identity memory for angry faces in elderly depressed patients. Savaskan E; Müller SE; Böhringer A; Schulz A; Schächinger H Int J Neuropsychopharmacol; 2008 May; 11(3):381-8. PubMed ID: 17697395 [TBL] [Abstract][Full Text] [Related]
26. Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model. Montgomery SA; Loft H; Sánchez C; Reines EH; Papp M Pharmacol Toxicol; 2001 May; 88(5):282-6. PubMed ID: 11393591 [TBL] [Abstract][Full Text] [Related]
27. Acute 5-HT Papp N; Koncz S; Kostyalik D; Kitka T; Petschner P; Vas S; Bagdy G Front Pharmacol; 2019; 10():1636. PubMed ID: 32063851 [TBL] [Abstract][Full Text] [Related]
28. Neonatal Toxicity From Escitalopram Use Degiacomo J; Luedtke S J Pediatr Pharmacol Ther; 2016; 21(6):522-526. PubMed ID: 28018155 [TBL] [Abstract][Full Text] [Related]
29. Yawning as a Rare Side Effect With Increased Escitalopram Dose: A Case Report. Sinha N; Patil R; Kotla R; Sahu N Cureus; 2024 Jun; 16(6):e61559. PubMed ID: 38962587 [TBL] [Abstract][Full Text] [Related]
30. Stereoisomers in Psychiatry: The Case of Escitalopram. Burke WJ; Kratochvil CJ Prim Care Companion J Clin Psychiatry; 2002 Feb; 4(1):20-24. PubMed ID: 15014731 [TBL] [Abstract][Full Text] [Related]
31. Escitalopram-induced liver injury: A case report and review of literature. Ng QX; Yong CSK; Loke W; Yeo WS; Soh AYS World J Hepatol; 2019 Oct; 11(10):719-724. PubMed ID: 31749902 [TBL] [Abstract][Full Text] [Related]
32. Micelle enhanced fluorimetric and thin layer chromatography densitometric methods for the determination of (+/-) citalopram and its S-enantiomer escitalopram. Taha EA; Salama NN; Wang S Anal Chem Insights; 2009 Apr; 4():1-9. PubMed ID: 19652757 [TBL] [Abstract][Full Text] [Related]
34. Corrigendum: Saylor RA; Hersey M; West A; Buchanan AM; Berger SN; Nijhout HF; Reed MC; Best J; Hashemi P Front Neurosci; 2019; 13():726. PubMed ID: 31354425 [TBL] [Abstract][Full Text] [Related]
35. Investigating the relationship between hippocampus/dentate gyrus volume and hypothalamus metabolism in participants with major depressive disorder. Lin K; Sunko D; Wang J; Yang J; Parsey RV; DeLorenzo C Sci Rep; 2024 May; 14(1):10622. PubMed ID: 38724691 [TBL] [Abstract][Full Text] [Related]
36. Lower sertraline plasma concentration in patients co-medicated with clozapine-Implications for pharmacological augmentation strategies in schizophrenia. Gaebler AJ; Haen E; Omar NB; Endres K; Hiemke C; Schoretsanitis G; Paulzen M Pharmacol Res Perspect; 2023 Apr; 11(2):e01065. PubMed ID: 36825450 [TBL] [Abstract][Full Text] [Related]